Johan Carlberg
Portfolio Manager
At Alphinity we invest in quality, undervalued companies with underestimated earnings expectations. Earnings and earnings expectations ultimately drive share prices over time, while valuation keeps us disciplined, and quality factors control risk.
Our proven rigorous investment process, using a deep and unique foundation of qualitative and quantitative research from our highly experienced team, ensures we are investing with conviction in a diversified portfolio of companies that are at the right point of their earnings cycle, regardless of broader market conditions or style. This has allowed Alphinity to deliver consistent, repeatable excess returns over time whilst maintaining relatively lower levels of risk.
Alphinity Australian Share Fund –
Performance (after fees) as at 30 September 2020
| Quarter (%) |
1 year (%) |
3 years (% p.a.) |
5 years (% p.a.) |
7 years (% p.a.) |
10 years (% p.a.) |
Since inception (% p.a.) |
|
| Alphinity Australian Share Fund | 0.4 | -7.9 | 5.6 | 7.7 | 6.2 | 7.7 | 8.1 |
| S&P/ASX 300 Accumulation Index | -0.1 | -10.0 | 4.9 | 7.4 | 6.0 | 6.9 | 7.3 |
Alphinity Concentrated Australian Share Fund –
Performance (after fees) as at 30 September 2020
| Quarter (%) |
1 year (%) |
3 years (% p.a.) |
5 years (% p.a.) |
7 years (% p.a.) |
10 years (% p.a.) |
Since inception (% p.a.) |
|
| Alphinity Concentrated Australian Share Fund | 0.5 | -8.7 | 5.6 | 8.8 | 7.5 | 8.6 | 9.1 |
| S&P/ASX 200 Accumulation Index | -0.4 | -10.2 | 4.8 | 7.3 | 5.9 | 6.9 | 7.3 |
Alphinity Australian Share Fund and Alphinity Concentrated Australian Share Fund: the Funds changed investment manager and investment methodology on 12 July 2010, at which time Alphinity Investment Management commenced managing the Funds and started transitioning of the portfolios to a structure consistent with Alphinity’s investment philosophy. The transition was completed on 31 August 2010. Therefore, the inception date for the returns for the Funds is 1 September 2010.
For performance for previous periods please contact Fidante Partners Investor Services team on 13 51 53 (during Sydney business hours). Returns are calculated after fees have been deducted assuming reinvestment of distributions. No allowance is made for tax. Past performance is not a reliable indicator of future performance.
To find out more about the Alphinity Australian Share Fund, Alphinity Australian Equity Fund or Alphinity Concentrated Australian Share Fund, contact your local Fidante Partners Business Development Manager or call the Fidante Partners Adviser Services Team on 1800 195 853.
For step by step instructions on how to invest, visit the Apply Now page of our website:
| Fund | Alphinity Australian Share Fund | Alphinity Concentrated Australian Share Fund |
| Investment objective | To outperform the benchmark after costs over rolling five year periods | To outperform the benchmark after costs over rolling five year periods |
| Benchmark | S&P/ASX 300 Accumulation Index | S&P/ASX 200 Accumulation Index |
| Stocks held in portfolio | 35-55 stocks | 20-35 stocks |
| Minimum investment timeframe | At least five years | At least five years |
| Minimum initial investment | $10,000 or $1,000 with Regular Savings Plan | $10,000 or $1,000 with Regular Savings Plan |
| Management fee | 0.90% p.a. | 0.80% p.a. |
| Performance fee | N/A | 15% of the Fund’s return above the S&P/ASX 200 Accumulation Index |
| Distribution frequency | Quarterly | Quarterly |
| APIR code | PAM0001AU | HOW0026AU |
| mFund ticker | ALH01 | ALH02 |
Portfolio Manager, Stuart Welch discusses the post-COVID-19 outlook for the healthcare sector.
On our 10 year anniversary, Alphinity’s principals reflect on the changing investment landscape and greatest successes of the business.
How do travel restrictions and remote working affect the Alphinity team’s research effort and information gathering process? Andrew Martin discusses.
Andrew Martin offers an insight into the importance of balancing trust in your investment philosophy with evolving market trends.
In this Q&A, Livewire spoke with Stephane Andre about what attracted him to Fortescue Metals Group, and why he thinks more upgrades are incoming.
Stuart Welch shares his views on who will be the winners and losers in the Australian health care market as we recover from the pandemic.
Andrew Martin discusses banks in the context of the current market situation.
